Cwm LLC increased its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 67.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,545 shares of the real estate investment trust's stock after acquiring an additional 15,947 shares during the period. Cwm LLC's holdings in Omega Healthcare Investors were worth $1,449,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also added to or reduced their stakes in the company. Vanguard Personalized Indexing Management LLC increased its holdings in shares of Omega Healthcare Investors by 11.7% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 30,922 shares of the real estate investment trust's stock valued at $1,133,000 after purchasing an additional 3,227 shares during the period. Concurrent Investment Advisors LLC boosted its position in Omega Healthcare Investors by 7.4% in the second quarter. Concurrent Investment Advisors LLC now owns 30,853 shares of the real estate investment trust's stock valued at $1,131,000 after buying an additional 2,124 shares during the last quarter. Aberdeen Group plc increased its holdings in Omega Healthcare Investors by 3.5% in the 2nd quarter. Aberdeen Group plc now owns 1,166,202 shares of the real estate investment trust's stock worth $42,193,000 after buying an additional 38,952 shares during the period. IFP Advisors Inc raised its position in Omega Healthcare Investors by 6.1% during the 2nd quarter. IFP Advisors Inc now owns 111,938 shares of the real estate investment trust's stock worth $4,103,000 after buying an additional 6,393 shares during the last quarter. Finally, Callan Family Office LLC purchased a new position in Omega Healthcare Investors during the 2nd quarter worth approximately $249,000. Hedge funds and other institutional investors own 65.25% of the company's stock.
Omega Healthcare Investors Price Performance
Shares of Omega Healthcare Investors stock opened at $41.10 on Tuesday. The firm has a market cap of $12.12 billion, a PE ratio of 25.37, a P/E/G ratio of 1.92 and a beta of 0.70. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The business has a 50-day moving average price of $41.60 and a 200 day moving average price of $38.92.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating the consensus estimate of $0.45 by $0.32. The company had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.Omega Healthcare Investors's quarterly revenue was up 11.8% compared to the same quarter last year. During the same period last year, the company earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.5%. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.
Insider Transactions at Omega Healthcare Investors
In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director owned 18,654 shares in the company, valued at $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several analysts have recently commented on OHI shares. Truist Financial upped their price objective on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Royal Bank Of Canada boosted their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research report on Thursday, August 7th. Cantor Fitzgerald began coverage on Omega Healthcare Investors in a research report on Wednesday, October 1st. They set an "overweight" rating and a $50.00 price target on the stock. Wells Fargo & Company lifted their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Finally, Weiss Ratings reissued a "buy (b)" rating on shares of Omega Healthcare Investors in a report on Wednesday, October 8th. Six analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $44.38.
Check Out Our Latest Report on OHI
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.